Skip to main content

Month: May 2021

Adicet Bio to Participate in Upcoming Investor Conferences

MENLO PARK, Calif., May 18, 2021 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that company management will participate in two upcoming virtual investor conferences in May and June. Details of the events are as follows: UBS Global Healthcare Virtual Conference, May 24-26, 2021Chen Schor, President and Chief Executive Officer, will present on Wednesday, May 26, 2021, at 7:00 AM ET. The JMP Securities Life Sciences Conference, June 16-17, 2021 Chen Schor, President and Chief Executive Officer, will participate in a fireside chat on Wednesday, June 16, 2021 at 3:00 PM ET. Live audio webcasts of the presentations can be accessed on the Investors section of Adicet Bio’s website at https://investor.adicetbio.com....

Continue reading

SP Plus Corporation Elects Diana Sands to Board of Directors; CEO Marc Baumann Assumes Chairman Role following Karen Garrison’s Retirement

Diana SandsDiana SandsCHICAGO, May 18, 2021 (GLOBE NEWSWIRE) — SP Plus Corporation (SP+), (Nasdaq: SP), a leading provider of technology-driven mobility solutions for aviation, commercial, hospitality and institutional clients throughout North America, today announced membership changes to its Board of Directors. The stockholders of SP+ elected Diana Sands to serve as the newest member of its Board of Directors. Ms. Sands brings more than 30 years of business experience having held senior finance and governance positions across multiple industries. She retired from The Boeing Company in 2020, after nearly two decades, where she most recently served as Senior Vice President of the Office of Internal Governance and Administration. In that role, she oversaw internal audit, ethics & investigations, compliance...

Continue reading

Olema Oncology to Participate at the Jefferies 2021 Virtual Healthcare Conference

SAN FRANCISCO, May 18, 2021 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced that Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will participate in a virtual fireside chat at the Jefferies 2021 Virtual Healthcare Conference on Tuesday, June 1, 2021 at 4:30 p.m. ET (1:30 p.m. PT). A live webcast of the presentation may be accessed under the Investors & Media section of Olema’s website (www.olema.com) and will be archived for 14 days. About Olema OncologyOlema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s...

Continue reading

Open Lending Signs Westerra Credit Union to the Lenders Protection™ Program

Westerra CU partners with Open Lending to help serve the underserved AUSTIN, Texas, May 18, 2021 (GLOBE NEWSWIRE) — Open Lending (NASDAQ: LPRO) provides loan analytics, risk-based pricing, risk modeling, and default insurance to auto lenders throughout the United States. The company announced today that Westerra Credit Union, a $1.9 billion institution based in Denver, CO, has selected Open Lending’s Lenders Protection™ program to increase their auto loan volume and expand their reach within their community. “Open Lending will help us better serve the underserved by allowing us to do more auto loans for members who typically might not find good financing options,” says Jared Dryer, VP of Consumer Lending for Westerra Credit Union. Open Lending’s flagship product, Lenders Protection™, is a unique auto lending enablement platform....

Continue reading

PubMatic to Present at Upcoming Investor Conference

REDWOOD CITY, Calif., May 18, 2021 (GLOBE NEWSWIRE) — PubMatic, Inc. (Nasdaq: PUBM), a sell-side platform that delivers superior outcomes for digital advertising, today announced that members of its management team are scheduled to present at an upcoming investor conference. Details for the event are as follows: Evercore ISI Inaugural TMT ConferenceWednesday, June 9, 2021 at 11:45 am ET The presentation will be webcast live on the investor relations section of PubMatic’s website at https://investors.pubmatic.com/. Replays of the presentation will be available on the website following the completion of each event. About PubMatic PubMatic delivers superior revenue to publishers by being an SSP of choice for agencies and advertisers. PubMatic’s cloud infrastructure platform for digital advertising empowers app developers and publishers...

Continue reading

Cardlytics to Host Virtual Investor Day on June 10

ATLANTA, May 18, 2021 (GLOBE NEWSWIRE) — Cardlytics, Inc., (NASDAQ: CDLX), one of the largest digital advertising platforms, announced today that it will host a virtual Investor Day on Thursday, June 10, 2021.The company’s executive team is scheduled to begin presentations at 9:30 a.m. ET. Presenting executives include:Lynne Laube, Co-Founder & CEO Andy Christiansen, Chief Financial Officer Ross McNab, President of North America Advertising Michael Akkerman, Chief Product & Strategy Officer Farrell Hudzik, Executive Vice President, Financial InstitutionsThe event can be accessed through a live webcast, which will be available on Cardlytics’ investor relations website at ir.cardlytics.com. A replay will also be archived on this website. About CardlyticsCardlytics (NASDAQ: CDLX) is a digital advertising platform....

Continue reading

Century Aluminum Announces New Officer Appointments

John DeZee Named EVP, General Counsel & Secretary; Matt Aboud Named SVP, Strategy and Business Development CHICAGO, May 18, 2021 (GLOBE NEWSWIRE) — Century Aluminum Company (NASDAQ: CENX) announced today that it has elected two new officers of the Company: John DeZee will assume the role of Executive Vice President, General Counsel and Secretary and Matt Aboud will assume the role of Senior Vice President, Strategy and Business Development, both effective immediately. EVP, General Counsel & Secretary Michael Bless, Century’s President and Chief Executive Officer, commented, “Our Board and I are delighted to announce John’s promotion to this critically important position. John has the firm respect of his colleagues and of the Company’s key partners in the U.S. and in Iceland. He has played a significant...

Continue reading

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NOVATO, Calif., May 18, 2021 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of non-qualified stock options to purchase an aggregate of 4,677 shares of common stock of the company and 7,100 restricted stock units of the company’s common stock to a newly hired non-executive officer of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of May 16, 2021, as an inducement material to the new employee entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4). The restricted stock units vest over four years,...

Continue reading

SAVE FOODS, INC. ANNOUNCES CLOSING OF $12 MILLION PUBLIC OFFERING AND NASDAQ LISTING

Tel Aviv, Israel, May 18, 2021 (GLOBE NEWSWIRE) — Save Foods, Inc. (“Save Foods” or the “Company”) (Nasdaq: SVFD), an agri-food-tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure food safety of fresh fruits and vegetables, today announced the closing of its underwritten public offering of 1,090,909 shares of Common Stock at a price to the public of $11.00 per share. The gross proceeds to the Company from this offering were approximately $12,000,000, before deducting underwriting discounts, commissions and other offering expenses, and excluding the exercise of the over-allotment option, if any. Save Foods has granted the underwriter a 45-day option to purchase up to 163,636 additional shares of Common Stock to cover over-allotments, if any, at the public...

Continue reading

Inventronics Announces 2021 Q1 Financial Results

CALGARY, Alberta, May 18, 2021 (GLOBE NEWSWIRE) — Inventronics Limited (“Inventronics” or the “Corporation”) (IVX:TSX Venture), a designer and manufacturer of enclosures for the telecommunications, electric transmission, cable television and other industries in North America, today announced its unaudited 2021 Q1 financial results. For the three months ended March 31, 2021, Inventronics reported net earnings of $181,000, or 4.0 cents per share, on revenue of $1,800,000 compared to net earnings of $44,000, or 1.0 cents per share, on revenue of $1,044,000 for the three months ended March 31, 2020. The increase in revenue is a result of increased demand in both Canada and the USA for internet bandwidth and changing communication technologies that utilize the Corporation’s enclosures.Selected Financial Information                         Income...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.